|
|
Article: Cadence Files For $86M IPO; Osiris Provides Price Range.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Cadence Pharmaceuticals Inc. filed for its initial public offering, hoping to raise as much as $86 million to support clinical development of its two late-stage candidates targeting pain and infection in hospital settings.
The San Diego-based firm has not yet disclosed the number of shares or share price, and what the company would be able to pull in remains to be seen, as the current environment is downsizing IPOs. In fact, stem cell firm Osiris Therapeutics Inc. on Monday set its share amount and price range that cuts its IPO expectations by half.
Representatives of Cadence, which anticipates a Nasdaq listing ticker symbol of ...